S'abonner

ASGE consensus recommendations on the endoscopic management of eosinophilic esophagitis — part 2: disease assessment, monitoring, and pediatric considerations - 08/01/26

Doi : 10.1016/j.gie.2025.10.032 
Evan S. Dellon, MD, MPH 1, , , Gary W. Falk, MD, MS, MASGE 2, , David A. Katzka, MD 3, , Jenifer Lightdale, MD, MPH 4, , Amanda B. Muir, MD 5, , Albert J. Bredenoord, MD, PhD 6, Dominique D. Bailey, MD, MSEd 7, Joy W. Chang, MD, MS 8, Glenn T. Furuta, MD 9, Nirmala Gonsalves, MD 10, Thomas Greuter, MD 11, Sandeep K. Gupta, MD 12, Girish Hiremath, MD, MPH 13, Jennifer L. Horsley-Silva, MD 14, Alfredo J. Lucendo, MD, PhD 15, Kristle L. Lynch, MD 16, Calies Menard-Katcher, MD 17, Fouad Moawad, MD 18, Salvatore Oliva, MD, PhD 19, Kathryn A. Peterson, MD 20, Hamish Philpott, MD 21, Philip E. Putnam, MD 22, Alain M. Schoepfer, MD 23, Diana L. Snyder, MD 24, Alex Straumann, MD 25, Josh B. Wechsler, MD, MSCI 26, Prateek Sharma, MD 27, ,
1 Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA 
2 Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA 
3 Division of Gastroenterology and Hepatology, Columbia University, New York, New York, USA 
4 Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA 
5 Division of Pediatric Gastroenterology, Department of Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA 
6 Department of Gastroenterology, Amsterdam University Medical Center, Amsterdam, the Netherlands 
7 Division Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA 
8 Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA 
9 Gastrointestinal Eosinophilic Diseases Program, Department of Pediatrics, University of Colorado School of Medicine, Section of Pediatric Gastroenterology and Hepatology, Children's Hospital Colorado, Aurora, Colorado, USA 
10 Division of Gastroenterology & Hepatology, Northwestern University – Feinberg School of Medicine, Chicago, Illinois, USA 
11 Division of Gastroenterology and Hepatology, EOC Lugano, Università della Svizzera italiana, Lugano, Switzerland 
12 Division of Pediatric Gastroenterology, University of Alabama at Birmingham/Children's of Alabama, Birmingham, Alabama, USA 
13 Division of Pediatric Gastroenterology, Department of Pediatrics, Monroe Carrell Jr Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, Tennessee, USA 
14 Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, Arizona, USA 
15 Department of Gastroenterology, Hospital General de Tomelloso, Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), Instituto de Investigación Sanitaria Princesa, Madrid, Spain 
16 Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA 
17 Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Colorado School of Medicine, Digestive Health Institute, Children's Hospital Colorado, Aurora, Colorado, USA 
18 Division of Gastroenterology, Scripps Clinic, La Jolla, California, USA 
19 Pediatric Gastroenterology and Liver Unit, Maternal and Child Health Department, University Hospital - Umberto I, Sapienza - University of Rome, Rome, Italy 
20 Division of Gastroenterology, Department of Medicine, University of Utah, Salt Lake City, Utah, USA 
21 Department of Gastroenterology NALHN, University of Adelaide, Adelaide, South Australia 
22 Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA 
23 Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland 
24 Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA 
25 Department of Gastroenterology University Hospital Zurich, Zurich, Switzerland 
26 Division of Gastroenterology, Hepatology & Nutrition, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA 
27 VA Medical Center and University of Kansas School of Medicine, Kansas City, Missouri, USA 

Corresponding author: Evan S. Dellon, MD, MPH, Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, NC, USA. American Society for Gastrointestinal Endoscopy 3300 Woodcreek Drive Downers Grove Illinois 60515 USA
Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Thursday 08 January 2026

Abstract

Esophagogastroduodenoscopy is essential to evaluate symptoms of suspected eosinophilic esophagitis (EoE), assess endoscopic findings, obtain biopsy specimens for histopathologic evaluation, perform esophageal dilation, confirm the diagnosis, and monitor the condition. The American Society for Gastrointestinal Endoscopy (ASGE) previously provided consensus recommendations on the approach to endoscopy in EoE across topics of endoscopic diagnosis, endoscopic grading, and esophageal dilation. Because additional areas of endoscopy still required guidance, we performed an independent modified Delphi process focusing on pediatric considerations, disease assessment, and disease monitoring. A core group of EoE experts reviewed published guidelines and developed a set of patient-centered recommendation statements informed by literature review. A multidisciplinary group of adult and pediatric international EoE experts then voted on the statements over 2 Delphi rounds. All statements with 80% agreement were accepted for inclusion. This process yielded 28 consensus statements. Pediatric-specific statements covered when to suspect EoE and perform endoscopy, how to grade endoscopic severity, and when and how to perform esophageal dilation in children. Statements across all age ranges addressed the role of less-invasive monitoring, performing diagnostic endoscopy off treatment, the need to consider symptoms, endoscopic features, and histologic findings when assessing disease activity, treatment-based monitoring intervals, and the approach to esophageal biopsies during monitoring. Coupled with the original consensus work, we provide a comprehensive endoscopic approach to EoE as well as practical guidance for procedure-related aspects in the field to facilitate high-quality endoscopic care to patients with EoE.

Le texte complet de cet article est disponible en PDF.

Abbreviations : ASGE, EGD, EGIDs, EoE, EREFS, EST, GERD, I-SEE, MBP, PPIs, uTNE


Plan


 This document was reviewed and approved by the Governing Board of the American Society for Gastrointestinal Endoscopy.


© 2025  American Society for Gastrointestinal Endoscopy. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.